CA2060154A1 - Angiotensin ii receptor blocking quinazolones - Google Patents

Angiotensin ii receptor blocking quinazolones

Info

Publication number
CA2060154A1
CA2060154A1 CA002060154A CA2060154A CA2060154A1 CA 2060154 A1 CA2060154 A1 CA 2060154A1 CA 002060154 A CA002060154 A CA 002060154A CA 2060154 A CA2060154 A CA 2060154A CA 2060154 A1 CA2060154 A1 CA 2060154A1
Authority
CA
Canada
Prior art keywords
carbon atoms
lower alkyl
quinazolinone
butyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002060154A
Other languages
English (en)
French (fr)
Inventor
Aranapakam M. Venkatesan
Jeremy I. Levin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2060154A1 publication Critical patent/CA2060154A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
CA002060154A 1991-01-30 1992-01-28 Angiotensin ii receptor blocking quinazolones Abandoned CA2060154A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64849291A 1991-01-30 1991-01-30
US07/648,492 1991-01-30

Publications (1)

Publication Number Publication Date
CA2060154A1 true CA2060154A1 (en) 1992-07-31

Family

ID=24601009

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002060154A Abandoned CA2060154A1 (en) 1991-01-30 1992-01-28 Angiotensin ii receptor blocking quinazolones

Country Status (23)

Country Link
US (2) US5290780A (en:Method)
EP (1) EP0497150B1 (en:Method)
JP (1) JP2758766B2 (en:Method)
KR (1) KR920014805A (en:Method)
CN (1) CN1037440C (en:Method)
AT (1) ATE164158T1 (en:Method)
AU (2) AU642573B2 (en:Method)
CA (1) CA2060154A1 (en:Method)
CZ (1) CZ281429B6 (en:Method)
DE (1) DE69224763T2 (en:Method)
DK (1) DK0497150T3 (en:Method)
ES (1) ES2117014T3 (en:Method)
FI (1) FI920217A7 (en:Method)
GR (1) GR3026592T3 (en:Method)
HU (1) HUT61748A (en:Method)
IE (1) IE920142A1 (en:Method)
IL (1) IL100711A0 (en:Method)
NO (1) NO920298L (en:Method)
NZ (1) NZ241343A (en:Method)
PL (1) PL293316A1 (en:Method)
SK (1) SK279004B6 (en:Method)
TW (1) TW282467B (en:Method)
ZA (1) ZA92392B (en:Method)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290780A (en) * 1991-01-30 1994-03-01 American Cyanamid Co. Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
US5385894A (en) * 1991-03-06 1995-01-31 Merck & Co., Inc. Disubstituted 6-aminoquinazolinones
EP0618207B1 (en) * 1993-03-24 1999-01-07 American Home Products Corporation Substituted pyridopyrimidines as antihypertensives
US5358951A (en) * 1993-04-23 1994-10-25 American Cyanamid Company Angiotensin II receptor blocking 2, 3, 6 substituted quinazolinones
US5610301A (en) * 1993-07-01 1997-03-11 American Cyanamid Company Process for the regioselective n-alkylation of quinazolinones
US5342944A (en) * 1993-07-19 1994-08-30 American Cyanamid Company Process for the preparation of 2-alkyl-3,5,6,7- or 8-substituted-4(3H)-quinazolinones
US5338736A (en) * 1993-10-07 1994-08-16 American Cyanamid Company Angiotensin II receptor blocking 2,3,6-substituted quinazolinones
WO1996009301A1 (en) * 1994-09-20 1996-03-28 Wakunaga Seiyaku Kabushiki Kaisha Process for producing n-biphenylmethylthiadiazoline derivative or salt thereof and intermediate for producing the same
CZ390097A3 (cs) * 1995-06-07 1998-06-17 American Home Products Corporation Způsob přípravy derivátů bifenylu
US5760220A (en) * 1995-06-07 1998-06-02 American Home Products Corporation Process for preparation of biphenyl derivatives
US5739330A (en) * 1996-02-05 1998-04-14 Hoechst Celanese Corporation Process for preparing quinazolones
US5763608A (en) * 1996-02-05 1998-06-09 Hoechst Celanese Corporation Process for preparing pyrimidine derivatives
US6638937B2 (en) 1998-07-06 2003-10-28 Bristol-Myers Squibb Co. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
GB0223730D0 (en) * 2002-10-11 2002-11-20 Novartis Ag Organic compounds
CN1706169A (zh) * 2002-10-18 2005-12-07 皇家飞利浦电子股份有限公司 用于即时电视中的元数据保护的方法、系统、装置、信号和计算机程序产品
EP1558260A4 (en) * 2002-11-04 2006-10-25 Nps Pharma Inc CHINAZOLINONE COMPOUNDS AS CALCILYTIC
GB0412769D0 (en) * 2004-06-08 2004-07-07 Novartis Ag Organic compounds
EP2079739A2 (en) * 2006-10-04 2009-07-22 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
AU2009256157B2 (en) 2008-06-04 2014-12-18 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
JP2011528375A (ja) 2008-07-16 2011-11-17 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
BR112014030473A2 (pt) 2012-06-13 2017-06-27 Hoffmann La Roche novo diazaespirocicloalcano e azaespirocicloalcano
SI2900669T1 (sl) 2012-09-25 2019-12-31 F. Hoffmann-La Roche Ag Derivati heksahidropirolo(3,4-C)pirola in sorodne spojine kot zaviralci avtotaksina (ATX) in kot zaviralci tvorbe lizofosfatidne kisline (LPA) za zdravljenje npr. bolezni ledvic
AR095079A1 (es) 2013-03-12 2015-09-16 Hoffmann La Roche Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
AU2014274812B2 (en) 2013-06-05 2018-09-27 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase C, method of making and using same
JP6496730B2 (ja) 2013-11-26 2019-04-03 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 新規なオクタヒドロ−シクロブタ［１，２−ｃ；３，４−ｃ’］ジピロール−２−イル
MX370659B (es) 2014-03-26 2019-12-19 Hoffmann La Roche Compuestos bicíclicos como inhibidores de producción de autotaxina (atx) y ácido lisofosfatídico (lpa).
MX373236B (es) 2014-03-26 2020-05-08 Hoffmann La Roche Compuestos condensados de [1,4]diazepina como inhibidores de producción de la autotaxina (atx) y ácido lisofosfatidico (lpa).
MA41898A (fr) 2015-04-10 2018-02-13 Hoffmann La Roche Dérivés de quinazolinone bicyclique
MX387736B (es) 2015-09-04 2025-03-18 Hoffmann La Roche Derivados de fenoximetilo.
CA2984585A1 (en) 2015-09-24 2017-03-30 F. Hoffmann-La Roche Ag New bicyclic compounds as dual atx/ca inhibitors
PE20180461A1 (es) 2015-09-24 2018-03-06 Hoffmann La Roche Nuevos compuestos biciclicos como inhibidores de la atx
KR20180054634A (ko) 2015-09-24 2018-05-24 에프. 호프만-라 로슈 아게 이중 오토탁신(atx)/탄산 무수화효소(ca) 억제제로서 신규한 이환형 화합물
KR20180054635A (ko) 2015-09-24 2018-05-24 에프. 호프만-라 로슈 아게 오토탁신(atx) 억제제로서 이환형 화합물
WO2018167113A1 (en) 2017-03-16 2018-09-20 F. Hoffmann-La Roche Ag New bicyclic compounds as atx inhibitors
CN110392679B (zh) 2017-03-16 2023-04-07 豪夫迈·罗氏有限公司 可用作双重atx/ca抑制剂的杂环化合物
CN107056715B (zh) * 2017-04-07 2019-07-30 江南大学 一种增强TRPV4-KCa2.3复合体耦联度的化合物及其在抗高血压中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
MX7829A (es) * 1986-08-21 1993-08-01 Pfizer Quinazolindionas y piridopirimindionas y procedimiento para su preparacion
CS272018B1 (en) * 1988-11-01 1990-12-13 Fisnerova Ludmila Ethereal derivatives of 4/3h/-quinazolinone
CA2020073A1 (en) * 1989-07-03 1991-01-04 Eric E. Allen Substituted quinazolinones as angiotensin ii antagonists
US5240928A (en) * 1989-07-03 1993-08-31 Merck & Co., Inc. Substituted quinazolinones as angiotensin II antagonists
EP0407342A3 (en) * 1989-07-06 1991-07-10 Ciba-Geigy Ag Pyrimidine derivatives
CA2037630C (en) * 1990-03-07 2001-07-03 Akira Morimoto Nitrogen-containing heterocylic compounds, their production and use
CA2053148A1 (en) * 1990-10-16 1992-04-17 Karnail Atwal Dihydropyrimidine derivatives
US5290780A (en) * 1991-01-30 1994-03-01 American Cyanamid Co. Angiotensin II receptor blocking 2,3,6 substituted quinazolinones

Also Published As

Publication number Publication date
EP0497150A1 (en) 1992-08-05
SK279004B6 (sk) 1998-05-06
JPH0578332A (ja) 1993-03-30
AU4490693A (en) 1993-11-18
ZA92392B (en) 1992-10-28
AU642573B2 (en) 1993-10-21
KR920014805A (ko) 1992-08-25
JP2758766B2 (ja) 1998-05-28
NZ241343A (en) 1994-06-27
HU9200278D0 (en) 1992-04-28
NO920298D0 (no) 1992-01-22
ATE164158T1 (de) 1998-04-15
AU1039792A (en) 1992-08-06
EP0497150B1 (en) 1998-03-18
HUT61748A (en) 1993-03-01
DK0497150T3 (da) 1998-06-02
ES2117014T3 (es) 1998-08-01
CZ281429B6 (cs) 1996-09-11
TW282467B (en:Method) 1996-08-01
FI920217L (fi) 1992-07-31
NO920298L (no) 1992-07-31
FI920217A0 (fi) 1992-01-17
DE69224763D1 (de) 1998-04-23
GR3026592T3 (en) 1998-07-31
FI920217A7 (fi) 1992-07-31
CS25592A3 (en) 1992-08-12
US5290780A (en) 1994-03-01
IL100711A0 (en) 1992-09-06
CN1037440C (zh) 1998-02-18
DE69224763T2 (de) 1998-07-09
CN1066847A (zh) 1992-12-09
AU647992B2 (en) 1994-03-31
PL293316A1 (en) 1993-08-23
US5405849A (en) 1995-04-11
IE920142A1 (en) 1992-07-29

Similar Documents

Publication Publication Date Title
CA2060154A1 (en) Angiotensin ii receptor blocking quinazolones
JP3117721B2 (ja) 新規なベンジルピリミジン類
US5389641A (en) Fused heterocyclic compounds, having angiotensin II antagonistic activity
CA2080705C (en) Substituted pyrimidines
US7022860B2 (en) Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents
JPH05239053A (ja) キノリン誘導体ならびにその製造方法および治療への応用
JPH0725870A (ja) アンジオテンシンｉｉ受容体ブロツキング性の２，３，６−置換されたキナゾリノン類
US5281603A (en) Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
US5294617A (en) Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
HU196989B (en) Process for producing quinoline derivatives and pharmaceuticals comprising same
US5281604A (en) Angiotensin II receptor blocking 2,3,6-substituted quinazolinones
CA2086647A1 (en) Chemical process
US5288720A (en) Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
US7091222B2 (en) Imidazole derivatives
US5284853A (en) Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
US5292734A (en) Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
KR0132001B1 (ko) 신규한 치환된 이미다졸 유도체
US5284852A (en) Angiotensin II receptor blocking 2,3,6-substituted quinazolinones
US5294611A (en) Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
WO2000050416A1 (en) 6-substituted heteroquinolinecarboxylic acid derivatives and addition salts thereof and processes for the preparation of both
US5292742A (en) Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
JP3466694B2 (ja) ピラゾロ〔１，５−ａ〕ピリミジン−７（４Ｈ）−オン誘導体
US5286729A (en) Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
AU669966B2 (en) Substituted pyridopyrimidines as antihypertensives
US5338736A (en) Angiotensin II receptor blocking 2,3,6-substituted quinazolinones

Legal Events

Date Code Title Description
FZDE Discontinued